I70.2 J44.9
Conditions
Interventions
Group 1: The study is designed as a diagnostic study. Patients will be evaluated for the study as part of the control of the known COPD. There is to be done an anamnesis, questionnaire, clinical exami
Sponsors
Praxis RechPneumologie
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patient capable of giving consent Diagnosed with COPD
Exclusion criteria
Exclusion criteria: Other lung diseases Serious comorbidities Incapable of giving consent / persons under 18 years of age. pregnancy Tumor therapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The anamnesis is followed by the ABI (Ankle Brachial Index) measurement, lung function test, determination of the walking distance ( 6 minutes’ walk distance) and measurement of hsCRP in serum The study is designed for a period of 6-12 months or a case number of 200 patients. The primary endpoint is the answer to the question of whether a PAD is present and the assignment to a stage of the PAD | — |
Secondary
| Measure | Time frame |
|---|---|
| How high is the unreported number of PAD in COPD patients. Which screening methods are useful in the routine for patients with COPD with regard to the question of the presence of PAD? | — |
Countries
Germany
Contacts
Public ContactAlexander Rech
Praxis RechPneumologie
Outcome results
None listed